Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date (2011)
- Authors:
- Autor USP: VAINZOF, MARIZ - IB
- Unidade: IB
- Subjects: CÉLULAS-TRONCO; DOENÇAS NEUROMUSCULARES; DOENÇAS DEGENERATIVAS
- Language: Inglês
- Imprenta:
- ISBN: 978-953-307-632-4
- Source:
- Título do periódico: Embryonic stem cells - differentiation and pluripotent alternatives
- Volume/Número/Paginação/Ano: 506 p
-
ABNT
ALMEIDA, Camila F. e AYUB-GUERRIERI, Danielle e VAINZOF, Mariz. Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date. Embryonic stem cells - differentiation and pluripotent alternatives. Tradução . Rijeka: Instituto de Biociências, Universidade de São Paulo, 2011. . Disponível em: http://cdn.intechopen.com/pdfs/21360/InTech-Myogenic_differentiation_of_es_cells_for_therapies_in_neuromuscular_diseases_progress_to_date.pdf. Acesso em: 16 maio 2024. -
APA
Almeida, C. F., Ayub-Guerrieri, D., & Vainzof, M. (2011). Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date. In Embryonic stem cells - differentiation and pluripotent alternatives. Rijeka: Instituto de Biociências, Universidade de São Paulo. Recuperado de http://cdn.intechopen.com/pdfs/21360/InTech-Myogenic_differentiation_of_es_cells_for_therapies_in_neuromuscular_diseases_progress_to_date.pdf -
NLM
Almeida CF, Ayub-Guerrieri D, Vainzof M. Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date [Internet]. In: Embryonic stem cells - differentiation and pluripotent alternatives. Rijeka: Instituto de Biociências, Universidade de São Paulo; 2011. [citado 2024 maio 16 ] Available from: http://cdn.intechopen.com/pdfs/21360/InTech-Myogenic_differentiation_of_es_cells_for_therapies_in_neuromuscular_diseases_progress_to_date.pdf -
Vancouver
Almeida CF, Ayub-Guerrieri D, Vainzof M. Myogenic differentiation of ES cells for therapies in neuromuscular diseases: progress to date [Internet]. In: Embryonic stem cells - differentiation and pluripotent alternatives. Rijeka: Instituto de Biociências, Universidade de São Paulo; 2011. [citado 2024 maio 16 ] Available from: http://cdn.intechopen.com/pdfs/21360/InTech-Myogenic_differentiation_of_es_cells_for_therapies_in_neuromuscular_diseases_progress_to_date.pdf - 233rd ENMC International Workshop: Clinical Trial Readiness for Calpainopathies, Naarden, The Netherlands, 15–17 September 2017
- Reviewing large LAMA2 deletions and duplications in congenital muscular dystrophy patients
- Behavioral responses in animal model of congenital muscular dystrophy 1D
- Effects of steroid hormones on myostatin expression and on genes of muscle regeneration pathway
- Estudo da atividade de quatro enzimas em tecido muscular de heterozigotas certas e afetadas por distrofias musculares progressivas: correlação com achados histológicos
- The contribution of muscle protein analysis in the diagnosis of genetic myopathies and in the understanding of the organization and maintenance of muscle fiber integrity
- Achados histológicos em biópsia muscular de eqüino com alterações neuromusculares
- Therapeutic potential of murine mesenchymal stem cells (MSC) from adipose tissue in the treatment of muscular dystrophy in the new double mutant mouse model for the genes dystrophin and large
- The mdx/SJL mouse: a new double mutant model for neuromuscular disorders with mutations in the dystrophin and dysferlin genes
- Heterozygous mutations in putative glycosyltransferase modulating the severity of the phenotype of muscular dystrophies
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas